美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72733-5901-2	72733-5901	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190215	N/A	BLA	BLA125559	Sanofi US Corporation	ALIROCUMAB	75 mg/mL	2 SYRINGE, GLASS in 1 CARTON (72733-5901-2) / 1 mL in 1 SYRINGE, GLASS (72733-5901-1)
72733-5902-2	72733-5902	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190215	N/A	BLA	BLA125559	Sanofi US Corporation	ALIROCUMAB	150 mg/mL	2 SYRINGE, GLASS in 1 CARTON (72733-5902-2) / 1 mL in 1 SYRINGE, GLASS (72733-5902-1)
0024-5901-00	0024-5901	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724	N/A	BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	75 mg/mL	1 SYRINGE, GLASS in 1 CARTON (0024-5901-00) / 1 mL in 1 SYRINGE, GLASS
0024-5901-01	0024-5901	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724	N/A	BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	75 mg/mL	1 SYRINGE, GLASS in 1 CARTON (0024-5901-01) / 1 mL in 1 SYRINGE, GLASS
0024-5901-02	0024-5901	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724	N/A	BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	75 mg/mL	2 SYRINGE, GLASS in 1 CARTON (0024-5901-02) / 1 mL in 1 SYRINGE, GLASS
0024-5902-00	0024-5902	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724	N/A	BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (0024-5902-00) / 1 mL in 1 SYRINGE, GLASS
0024-5902-01	0024-5902	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724	N/A	BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (0024-5902-01) / 1 mL in 1 SYRINGE, GLASS
0024-5902-02	0024-5902	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724	N/A	BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	150 mg/mL	2 SYRINGE, GLASS in 1 CARTON (0024-5902-02) / 1 mL in 1 SYRINGE, GLASS
61755-020-01	61755-020	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20201201	N/A	BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	75 mg/mL	1 SYRINGE, GLASS in 1 CARTON (61755-020-01) / 1 mL in 1 SYRINGE, GLASS
61755-020-02	61755-020	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20201201	N/A	BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	75 mg/mL	2 SYRINGE, GLASS in 1 CARTON (61755-020-02) / 1 mL in 1 SYRINGE, GLASS
61755-020-04	61755-020	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20201201	N/A	BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	75 mg/mL	1 SYRINGE, GLASS in 1 CARTON (61755-020-04) / 1 mL in 1 SYRINGE, GLASS
61755-021-01	61755-021	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20201201	N/A	BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (61755-021-01) / 1 mL in 1 SYRINGE, GLASS
61755-021-02	61755-021	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20201201	N/A	BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	150 mg/mL	2 SYRINGE, GLASS in 1 CARTON (61755-021-02) / 1 mL in 1 SYRINGE, GLASS
61755-021-04	61755-021	HUMAN PRESCRIPTION DRUG	Praluent	alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20201201	N/A	BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (61755-021-04) / 1 mL in 1 SYRINGE, GLASS